Articles citing this paper
cfArticle2ecfc1291681887$funcTITLE@501f9fb0
Christina Muzny A C , Arti Barnes B and Leandro Mena B
+ Author Affiliations
- Author Affiliations
A Division of Infectious Diseases, University of Alabama at Birmingham, ZRB 242, 1530 3rd Avenue South, Birmingham, AL 35294, USA.
B Division of Infectious Diseases, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.
C Corresponding author. Email: cmuzny@uab.edu
Sexual Health 9(4) 389-391 https://doi.org/10.1071/SH11114
Submitted: 11 August 2011 Accepted: 28 November 2011 Published: 20 January 2012
30 articles found in Crossref database.
Multidrug-Resistant Trichomoniasis: Successful Treatment With 3 Months of Twice-Daily Intravaginal Boric Acid
Seyedroudbari Sara,
McCloskey Kyle,
Muzny Christina A.,
Graziani Amy, Momplaisir Florence
Sexually Transmitted Diseases. 2023 50(7). p.452
A case of non-treated Trichomonas vaginalis infection and severe preterm labor with positive obstetrical outcome
Salakos E.,
Korb D.,
Morin C., Sibony O.
Journal of Gynecology Obstetrics and Human Reproduction. 2018 47(4). p.171
Data on Safety of Intravaginal Boric Acid Use in Pregnant and Nonpregnant Women: A Narrative Review
Mittelstaedt Rachel,
Kretz Alyssa,
Levine Michael,
Handa Victoria L.,
Ghanem Khalil G.,
Sobel Jack D.,
Powell Anna, Tuddenham Susan
Sexually Transmitted Diseases. 2021 48(12). p.e241
The Role of Purinergic Signaling in Trichomonas vaginalis Infection
Ferla Micheli, Tasca Tiana
Current Topics in Medicinal Chemistry. 2021 21(3). p.181
Diagnosis and Management ofTrichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines
Kissinger Patricia J,
Gaydos Charlotte A,
Seña Arlene C,
Scott McClelland R,
Soper David,
Secor W Evan,
Legendre Davey,
Workowski Kimberly A, Muzny Christina A
Clinical Infectious Diseases. 2022 74(Supplement_2). p.S152
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and AsymptomaticTrichomonas vaginalisInfections
Meites Elissa,
Gaydos Charlotte A.,
Hobbs Marcia M.,
Kissinger Patricia,
Nyirjesy Paul,
Schwebke Jane R.,
Secor W. Evan,
Sobel Jack D., Workowski Kimberly A.
Clinical Infectious Diseases. 2015 61(suppl 8). p.S837
The clinical spectrum ofTrichomonas vaginalisinfection and challenges to management
Muzny Christina A, Schwebke Jane R
Sexually Transmitted Infections. 2013 89(6). p.423
Chemotherapeutic options for the treatment of human trichomoniasis
Küng Erik,
Fürnkranz Ursula, Walochnik Julia
International Journal of Antimicrobial Agents. 2019 53(2). p.116
Successful treatment of refractory Trichomonas vaginalis infection using intravenous metronidazole
Hawkins Isobel,
Carne Christopher,
Sonnex Christopher, Carmichael Andrew
International Journal of STD & AIDS. 2015 26(9). p.676
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (2015)
Vaginitis in Nonpregnant Patients
Obstetrics & Gynecology. 2020 135(1). p.e1
Trichomonas vaginalis Treated With Boric Acid in a Metronidazole Allergic Female
Backus Kandis Vechelle,
Muzny Christina A., Beauchamps Laura S.
Sexually Transmitted Diseases. 2017 44(2). p.120
Sexually Transmitted Infections in HIV-Infected Adults and Special Populations (2017)
Antimicrobial Drug Resistance (2017)
Trichomoniasis
Van Gerwen Olivia T.,
Opsteen Skye A.,
Graves Keonte J., Muzny Christina A.
Infectious Disease Clinics of North America. 2023 37(2). p.245
Strategies for Prevention and Treatment of Trichomonas vaginalis Infections
Bouchemal Kawthar,
Bories Christian, Loiseau Philippe M.
Clinical Microbiology Reviews. 2017 30(3). p.811
Manual of
Clinical Microbiology (2015)
Intravaginal Metronidazole/Miconazole for the Treatment of Vaginal Trichomoniasis
Schwebke Jane R.,
Lensing Shelly Y., Sobel Jack
Sexually Transmitted Diseases. 2013 40(9). p.710
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski Kimberly A.,
Bachmann Laura H.,
Chan Philip A.,
Johnston Christine M.,
Muzny Christina A.,
Park Ina,
Reno Hilary,
Zenilman Jonathan M., Bolan Gail A.
MMWR. Recommendations and Reports. 2021 70(4). p.1
Intravaginal boric acid: is it an alternative therapeutic option for vaginal trichomoniasis?
Thorley Nicola, Ross Jonathan
Sexually Transmitted Infections. 2018 94(8). p.574
Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues
Kissinger Patricia
BMC Infectious Diseases. 2015 15(1).
Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection
Van Gerwen Olivia T., Muzny Christina A.
F1000Research. 2019 8 p.1666
Neglected Tropical Diseases - North America (2021)
Boric Acid for the Treatment of Vaginitis: New Possibilities Using an Old Anti‐Infective Agent: A Systematic Review
Lærkeholm Müller Matilde,
Damsted Petersen Christina,
Saunte Ditte Marie L., East-Innis Althea
Dermatologic Therapy. 2024 2024(1).
Persistent and recurrentTrichomonas vaginalisinfections: epidemiology, treatment and management considerations
Seña Arlene C,
Bachmann Laura H, Hobbs Marcia M
Expert Review of Anti-infective Therapy. 2014 12(6). p.673
The Antimicrobial Effect of Boric Acid on Trichomonas vaginalis
Brittingham Andrew, Wilson Wayne A.
Sexually Transmitted Diseases. 2014 41(12). p.718
Intravenous metronidazole, liquid tinidazole, and intra-vaginal boric acid to cure trichomonas in a patient with gastric bypass surgery
Butt Saira, Tirmizi Amir
International Journal of STD & AIDS. 2018 29(8). p.825
Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections
Jøraholmen May Wenche,
Škalko-Basnet Nataša,
Acharya Ganesh, Basnet Purusotam
European Journal of Pharmaceutical Sciences. 2015 79 p.112
Hydrogenosome Metabolism Is the Key Target for Antiparasitic Activity of Resveratrol against Trichomonas vaginalis
Mallo Natalia,
Lamas Jesús, Leiro José M.
Antimicrobial Agents and Chemotherapy. 2013 57(6). p.2476
In Vitro
Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole
Ghosh Arindam P.,
Aycock Cheri, Schwebke Jane R.
Antimicrobial Agents and Chemotherapy. 2018 62(4).
